Butaxamine
Butaxamine has been studied in 1 paper since 2022: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Dec 13, 2022: “Beta 2 Adrenergic Receptor Selective Antagonist Enhances Mechanically Stimulated Bone Anabolism in Aged Mice”.
See all 1 papers on butaxamine
At a glance
The findings reach mice, none yet in people. 1 lab in 1 country.
None of its findings points the other way.
- 1 lab in 1 country
- Funders: National Institute of Arthritis and Musculoskeletal and Skin Diseases and 1 more
- Animals1
What did studies of butaxamine find?
2Studies of butaxamine measured 2 outcomes: osteoblasts and periosteal bone formation.
Osteoblasts
no changein mice1
1 study
Osteoblasts
no changein mice1
Butaxamine showed no clear effect on osteoblasts in mice (contralateral unloaded tibia).
“Butax treatment did not alter osteoblast activity of contralateral tibias.”
Animalscontralateral unloaded tibiatibia
JBMR plus
Periosteal bone formation
upin mice1
1 study
Periosteal bone formation
upin mice1
Butaxamine increases periosteal bone formation in mice (combined with tibial cantilever bending loading).
“when loading was combined with Butax pretreatment, the anabolic response was significantly elevated compared with loading preceded by saline injection”
Animalscombined with tibial cantilever bending loadingtibia
JBMR plus